The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
17 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,262,763 in first-year total cost, median $197,055.
Most frequent study sections
- Cancer Biomarkers Study Section[CBSS]7
- Cancer Genetics Study Section[CG]2
- Cancer Molecular Pathobiology Study Section[CAMP]2
- Clinical Oncology Study Section[CONC]2
- Chemo/Dietary Prevention Study Section[CDP]1
Most frequent institutions
- UNIVERSITY OF MICHIGAN AT ANN ARBOR2
- ALBERT EINSTEIN COLLEGE OF MEDICINE1
- ARIZONA STATE UNIVERSITY-TEMPE CAMPUS1
- BETH ISRAEL DEACONESS MEDICAL CENTER1
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | Validation of 4-miRNA signature for early lung cancer detection1R21CA205414-01 | CHEN, GUOAN | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $218,987 | CONC |
| 2016 | Exploring MicroRNAs as Predictors of Cervical Intraepithelial Neoplasia Outcomes1R21CA188781-01A1 | CAMERON, JENNIFER ERIN | LSU HEALTH SCIENCES CENTER, LA | $190,530 | CBSS |
| 2016 | Discovery of Novel miRNAs and isomiRs and Use in Sub-typing TCGA Cancers1R21CA195204-01A1 | RIGOUTSOS, ISIDORE | THOMAS JEFFERSON UNIVERSITY, PA | $169,650 | CBSS |
| 2015 | Role of lncRNAs in Clinical Heterogeneity of Early Stage IGHV Unmutated CLL1R21CA191380-01A1 | JELINEK, DIANE F | MAYO CLINIC ROCHESTER, MN | $207,495 | CAMP |
| 2015 | Non-coding RNAs in serrated polyps identify patients with high colon cancer risk1R21CA191507-01A1 | DELKER, DON AKANTH, PRIYANKA | UNIVERSITY OF UTAH, UT | $205,103 | CBSS |
| 2015 | Identifying microRNA Targets for Early Detection of Myeloproliferative Neoplasms1R21CA189705-01A1 | JAMIESON, CATRIONA HELEN MACLEOD | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $202,275 | CBSS |
| 2015 | Autoantibodies against micro RNA for Early Cancer Detection1R21CA195222-01 | ZENG, GANG | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $197,212 | CBSS |
| 2015 | Mechanism for miR-21-modulated radioresistance1R21CA185882-01A1 | WANG, YA | EMORY UNIVERSITY, GA | $169,650 | RTB |
| 2015 | Hiring Non-toxic Virus Nanoparticles to Count Cancer Biomarker Molecules1R21CA195607-01 | MAO, CHUANBIN | UNIVERSITY OF OKLAHOMA, OK | $163,563 | NANO |
| 2015 | Exhaled microRNAs leveraged for lung cancer risk assessment1R21CA192168-01 | SPIVACK, SIMON D | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | $107,593 | CONC |
| 2014 | MicroRNA dysregulation and bladder cancer prognosis1R21CA182659-01 | ANDREW, ANGELINE SANDERSON | DARTMOUTH COLLEGE, NH | $246,645 | CBSS |
| 2014 | Long non-coding RNAs in pancreatic cancer1R21CA188059-01 | SUSSEL, LORI | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $208,800 | CG |
| 2014 | Functional characterization of pseudogenes as new biomarker in prostate cancer1R21CA176330-01A1 | PALANISAMY, NALLASIVAM | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $202,928 | CG |
| 2014 | MicroRNA, a new player for the NSAID sulindac to prevent colon cancer progression1R21CA182754-01A1 | XI, YAGUANG | UNIVERSITY OF SOUTH ALABAMA, AL | $197,055 | CDP |
| 2014 | Detection and validation of miRNA targets in breast cancer1R21CA179144-01A1 | MANGONE, MARCO | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | $194,217 | CAMP |
| 2014 | MicroRNAs for monitoring tumor progression and predicting response to therapy1R21CA179282-01A1 | WANG, LIZHONG | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $191,835 | CBSS |
| 2014 | Identifying lincRNAs that Mediate PI 3 Kinase Dependent Breast Cancer1R21CA181143-01 | TOKER, ALEX | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $189,225 | MONC |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.